ALPMY should take 4%ALPMY could grow and cross or at least touch the 20 days average around 13.25$
Would be a 4% growth
Next report date
Report period
Q1 2024
EPS estimate
0.06USD
Revenue estimate
2.63 BUSD
0.06USD
117.88 MUSD
11.09 BUSD
About ASTELLAS PHARMA
Sector
CEO
Naoki Okamura
Headquarters
Tokyo
Website
Founded
1923
FIGI
BBG000NVS6W6
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
